Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes

Journal of Leukocyte Biology

Volumn 77, Issue 3, 2005, Pages 303-310

  Tunheim, Gro ^a   Schjetne, Karoline W ^a   Fredriksen, Agnete B ^a   Sandlie, Inger ^a   Bogen, Bjarne ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Ab; Antigen presentation; CD4+ T cells; MHC class II; Monocyte

Indexed keywords

CALCIUM; CD14 ANTIGEN; EPITOPE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3C10; RECOMBINANT ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CALCIUM CELL LEVEL; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CLONING; CONTROLLED STUDY; DENDRITIC CELL; DRUG TARGETING; HUMAN; HUMAN CELL; HYBRIDOMA; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; HYBRIDOMAS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULINS; MICE; RECOMBINANT FUSION PROTEINS; VACCINES;

EID: 14244269001     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0804480     Document Type: Article

References (54)

1. Wang, R. F. (2001) The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol. 22, 269-276.
2. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., Nussenzweig, M. C. (1995) The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375, 151-155.
3. Tan, M. C., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J., Verwoerd, D., Mulder, A. A., van der Heiden, A. N., Scheidegger, D., Oomen, L. C., Ottenhoff, T. H., Tulp, A., Neefjes, J. J., Koning, F. (1997) Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27, 2426-2435.
4. Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C., Lanzavecchia, A., Pieters, J. (1997) The mannose receptor functions as a high-capacity and broad-specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27, 2417-2425.
5. Engering, A., Geijtenbeek, T. B., van Vliet, S. J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C. G., Piguet, V., van Kooyk, Y. (2002) The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168, 2118-2126.
6. Schjetne, K. W., Thompson, K. M., Aarvak, T., Fleckenstein, B., Sollid, L. M., Bogen, B. (2002) A mouse C-κ-specific T cell clone indicates that DC-SIGN is an efficient target for antibody-mediated delivery of T cell epitopes for MHC class II presentation. Int. Immunol. 14, 1423-1430.
7. Schjetne, K. W., Thompson, K. M., Nilsen, N., Flo, T. H., Fleckenstein, B., Iversen, J. G., Espevik, T., Bogen, B. (2003) Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J. Immunol. 171, 32-36.
8. Schjetne, K. W., Gundersen, H. T., Iversen, J. G., Thompson, K. M., Bogen, B. (2003) Antibody-mediated delivery of antigen to chemokine receptors on antigen-presenting cells results in enhanced CD4+ T cell responses. Eur. J. Immunol. 33, 3101-3108.
9. Akira, S., Takeda, K., Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
10. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., Beutler, B. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
11. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
12. Pugin, J., Heumann, I. D., Tomasz, A., Kravchenko, V. V., Akamatsu, Y., Nishijima, M., Glauser, M. P., Tobias, P. S., Ulevitch, R. J. (1994) CD14 is a pattern recognition receptor. Immunity 1, 509-516.
13. Gupta, D., Kirkland, T. N., Viriyakosol, S., Dziarski, R. (1996) CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271, 23310-23316.
14. Li, X., Bradford, B. U., Dalldorf, F., Goyert, S. M., Stimpson, S. A., Thurman, R. G., Makarov, S. S. (2004) CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Res. Ther. 6, R273-R281.
15. Vignal, C., Guerardel, Y., Kremer, L., Masson, M., Legrand, D., Mazurier, J., Elass, E. (2003) Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-α and IL-8 secretion by a CD14-Toll-like receptor 2-dependent mechanism. J. Immunol. 171, 2014-2023.
16. Devitt, A., Moffatt, O. D., Raykundalia, C., Capra, J. D., Simmons, D. L., Gregory, C. D. (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392, 505-509.
17. Grunwald, U., Fan, X., Jack, R. S., Workalemahu, G., Kallies, A., Stelter, F., Schutt, C. (1996) Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J. Immunol. 157, 4119-4125.
18. Casten, L. A., Pierce, S. K. (1988) Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J. Immunol. 140, 404-410.
19. Carayanniotis, G., Barber, B. H. (1987) Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature 327, 59-61.
20. Zanetti, M. (1992) Antigenized antibodies. Nature 355, 476-477.
21. Bona, C., Brumeanu, T. D., Zaghouani, H. (1994) Immunogenicity of microbial peptides grafted in self immunoglobulin molecules. Cell. Mol. Biol. (Noisy-le-grand) 40 (Suppl. 1), 21-30.
22. Lunde, E., Munthe, L. A., Vabo, A., Sandlie, I., Bogen, B. (1999) Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells. Nat. Biotechnol. 17, 670-675.
23. Lunde, E., Western, K. H., Rasmussen, I. B., Sandlie, I., Bogen, B. (2002) Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies. J. Immunol. 168, 2154-2162.
24. Eidem, J. K., Rasmussen, I. B., Lunde, E., Gregers, T. F., Rees, A. R., Bogen, B., Sandlie, I. (2000) Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation. J. Immunol. Methods 245, 119-131.
25. Rasmussen, I. B., Lunde, E., Michaelsen, T. E., Bogen, B., Sandlie, I. (2001) The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc. Natl. Acad. Sci. USA 98, 10296-10301.
26. Røtnes, J. S., Bogen, B. (1994) Ca2+ mobilization in physiologically stimulated single T cells gradually increases with peptide concentration (analog signaling). Eur. J. Immunol. 24, 851-858.
27. Lunde, E., Bogen, B., Sandlie, I. (1997) Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells. Mol. Immunol. 34, 1167-1176.
28. Norderhaug, L., Olafsen, T., Michaelsen, T. E., Sandlie, I. (1997) Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J. Immunol. Methods 204, 77-87.
29. Neuberger, M. S. (1983) Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J. 2, 1373-1378.
30. Van Voorhis, W. C., Steinman, R. M., Hair, L. S., Luban, J., Witmer, M. D., Koide, S., Cohn, Z. A. (1983) Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages. J. Exp. Med. 158, 126-145.
31. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
32. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., Kimoto, M. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
33. Lanzavecchia, A. (1985) Antigen-specific interaction between T and B cells. Nature 314, 537-539.
34. St Pierre, Y., Watts, T. H. (1990) MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A. J. Immunol. 145, 812-818.
35. Lanzavecchia, A., Abrignani, S., Scheidegger, D., Obrist, R., Dorken, B., Moldenhauer, G. (1988) Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J. Exp. Med. 167, 345-352.
36. Weiss, S., Bogen, B. (1989) B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 86, 282-286.
37. Flo, T. H., Halaas, O., Lien, E., Ryan, L., Teti, G., Golenbock, D. T., Sundan, A., Espevik, T. (2000) Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164, 2064-2069.
38. Michelsen, K. S., Aicher, A., Mohaupt, M., Hartung, T., Dimmeler, S., Kirschning, C. J., Schumann, R. R. (2001) The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J. Biol. Chem. 276, 25680-25686.
39. Thoma-Uszynski, S., Kiertscher, S. M., Ochoa, M. T., Bouis, D. A., Norgard, M. V., Miyake, K., Godowski, P. J., Roth, M. D., Modlin, R. L. (2000) Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165, 3804-3810.
40. Latz, E., Visintin, A., Lien, E., Fitzgerald, K. A., Monks, B. G., Kurt-Jones, E. A., Golenbock, D. T., Espevik, T. (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the Toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J. Biol. Chem. 277, 47834-47843.
41. Poussin, C., Foti, M., Carpentier, J. L., Pugin, J. (1998) CD14-dependent endotoxin internalization via a macropinocytic pathway. J. Biol. Chem. 273, 20285-20291.
42. Visintin, A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S. K., Segal, D. M. (2001) Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166, 249-255.
43. Sabroe, I., Jones, E. C., Usher, L. R., Whyte, M. K., Dower, S. K. (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol. 168, 4701-4710.
44. Uronen-Hansson, H., Allen, J., Osman, M., Squires, G., Klein, N., Callard, R. E. (2004) Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111, 173-178.
45. Dunzendorfer, S., Lee, H. K., Soldau, K., Tobias, P. S. (2004) TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J. Immunol. 173, 1166-1170.
46. Li, M. O., Sarkisian, M. R., Mehal, W. Z., Rakic, P., Flavell, R. A. (2003) Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302, 1560-1563.
47. Bender, A., Sapp, M., Schuler, G., Steinman, R. M., Bhardwaj, N. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121-135.
48. Watts, C. (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 15, 821-850.
49. Santoro, L., Reboul, A., Kerblat, I., Drouet, C., Colomb, M. G. (1996) Monoclonal IgG as antigens: reduction is an early intracellular event of their processing by antigen-presenting cells. Int. Immunol. 8, 211-219.
50. Zaghouani, H., Steinman, R., Nonacs, R., Shah, H., Gerhard, W., Bona, C. (1993) Presentation of a viral T cell epitope expressed in the CDR3 region of a self-immunoglobulin molecule. Science 259, 224-227.
51. Xiong, S., Gerloni, M., Zanetti, M. (1997) Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nat. Biotechnol. 15, 882-886.
52. Freimuth, P., Steinman, R. M. (1990) Insertion of myoglobin T-cell epitopes into the Escherichia coli alkaline phosphatase. Res. Microbiol. 141, 995-1001.
53. Evans, D. J., McKeating, J., Meredith, J. M., Burke, K. L., Katrak, K., John, A., Ferguson, M., Minor, P. D., Weiss, R. A., Almond, J. W. (1989) An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388, 340.
54. Snider, D. P., Segal, D. M. (1987) Targeted antigen presentation using crosslinked antibody heteroaggregates. J. Immunol. 139, 1609-1616.